BorealGenomics

Boreal, we are committed to improving cancer patient care by developing research tools and diagnostic tests based on monitoring tumor mutations in cell-free DNA in plasma. Currently, the connected target capture group can be used to analyze cell-free DNA, FFPE, and genomic DNA. Learn more about our early access program to try out the linked target capture in your lab. Boreal is developing other chained molecular chemistries for high-precision sequencing, targeted connection of unknown gene fusions, and other applications.